Douglas Lane & Associates LLC boosted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 73.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,574,455 shares of the real estate investment trust’s stock after purchasing an additional 1,090,130 shares during the quarter. Douglas Lane & Associates LLC owned approximately 0.37% of Healthpeak Properties worth $52,184,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp acquired a new stake in shares of Healthpeak Properties in the third quarter valued at approximately $1,093,576,000. JPMorgan Chase & Co. increased its position in Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after acquiring an additional 4,056,931 shares during the period. Geode Capital Management LLC bought a new stake in Healthpeak Properties during the 3rd quarter valued at $403,898,000. Charles Schwab Investment Management Inc. acquired a new position in Healthpeak Properties during the 3rd quarter worth $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Healthpeak Properties in the third quarter worth $175,697,000. 93.57% of the stock is currently owned by institutional investors.
Healthpeak Properties Stock Up 2.1 %
DOC traded up $0.42 during trading hours on Wednesday, hitting $20.33. 1,813,137 shares of the company’s stock were exchanged, compared to its average volume of 3,470,908. The stock has a market cap of $14.22 billion, a price-to-earnings ratio of 43.26, a PEG ratio of 2.31 and a beta of 1.14. Healthpeak Properties, Inc. has a 1-year low of $16.01 and a 1-year high of $23.26. The stock’s 50-day moving average is $21.24 and its two-hundred day moving average is $21.47. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93.
Healthpeak Properties Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.90%. The ex-dividend date was Monday, November 4th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 255.32%.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on the company. Wells Fargo & Company dropped their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 10th. Royal Bank of Canada upped their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their target price for the stock from $20.00 to $28.00 in a report on Monday, October 21st. Robert W. Baird upped their price target on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Finally, Mizuho lowered their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $24.08.
Get Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also
- Five stocks we like better than Healthpeak Properties
- How to Use the MarketBeat Stock Screener
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- 3 Warren Buffett Stocks to Buy Now
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What is a Death Cross in Stocks?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.